Spark Finland
- Advanced Therapies Europe
- Partner
)
SPARK Finland program is designed to increase the maturity of academic and clinical discoveries towards practical and value creating solutions in the health tech and life science space.
Program supports also career development by educating scientists, students and health care professionals on drug and health tech development and building the understanding of business aspects related to the discoveries.
We work in close relationship with innovation and technology transfer offices of our associated institutions.
In March 2021 Labiotech.eu – the leading digital media covering the European Biotech industry- selected SPARK Finland as TOP25 biotech incubators in Europe.
The Stanford SPARK program is the cornerstone for our program. It was established by Professor Daria Mochly-Rosen in 2006 for advancing new biomedical research discoveries into promising new treatments for patients. It provides top-notch mentoring and education, and a cost-effective model to generate proof of concept by using industry standards.
SPARK Finland follows the same principles that have been cornerstones of SPARK at Stanford, and our program is an official member of SPARK Global network.